Cargando…
Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study
OBJECTIVES: To study the efficacy of rituximab in active rheumatoid arthritis (RA) patients refractory to disease modifying anti-rheumatic drugs (DMARDs) including the tumor necrosis factor (TNF)-α antagonists. METHODS: Adult patients with active RA despite adequate therapies with conventional DMARD...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers Ltd.
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581826/ https://www.ncbi.nlm.nih.gov/pubmed/19088893 http://dx.doi.org/10.2174/1874312900701010001 |